Some links on our site may earn us a commission at no extra cost to you. Learn more.
This article is educational and reflects publicly reported product and regulatory information as of its publish date; it is not medical advice and makes no diagnostic or treatment claims. Wearable “trend” or “screening” features are not a substitute for a clinical blood pressure measurement, and anyone concerned about their blood pressure or a hypertension diagnosis should talk to a doctor or other qualified healthcare professional rather than relying on a device alone.
Short answer: a handful of wearables can now legitimately do something related to blood pressure, but almost none of them replace a cuff. Apple Watch (Series 9/10/11, Ultra 2/3) is FDA-cleared to flag a pattern consistent with hypertension over 30 days, not to give you a number. Omron’s HeartGuide is the only mainstream wrist wearable with an actual FDA-cleared inflatable cuff that produces a real oscillometric reading. Aktiia’s cuffless technology has FDA 510(k) clearance as a medical system, but the consumer product currently sold in the US under the Hilo brand is positioned as a wellness device, not that cleared system. Everything else — Samsung, Fitbit, most of Garmin — is either wellness-only or not offering blood pressure features in the US at all.
In This Guide
- Is Any Smartwatch Actually FDA-Cleared to Measure Blood Pressure?
- What’s the Difference Between a “Trend” Feature and a Real Reading?
- When Wearable Blood Pressure Monitoring Started Making Sense
- Which Cuffless Blood Pressure Wearables Are FDA-Cleared, and Which Are Just “Wellness”?
- Is There a Wearable With an Actual Blood Pressure Cuff?
- How Do the Different Technology Types Compare?
- How Accurate Is Cuffless Optical Blood Pressure Sensing, Really?
- Which Wearable Should You Buy for Which Health Goal?
- So Should You Buy a Blood Pressure Wearable in 2026?
- Blood Pressure Wearable Questions
Is Any Smartwatch Actually FDA-Cleared to Measure Blood Pressure?
Yes, but only for a narrow “notification” purpose, and only from Apple so far. Apple received FDA clearance in September 2025 for a hypertension notification feature on Apple Watch Series 9, 10, and 11, plus Ultra 2 and 3, according to coverage from MobiHealthNews and Cardiovascular Business. The feature shipped with watchOS 26 later that month.
Here’s the part that matters most: the watch never displays a blood pressure number. Its optical heart sensor collects data passively over roughly 30 days, and a machine-learning algorithm evaluates how the wearer’s blood vessels respond to each heartbeat, looking for patterns “consistent with hypertension.” Apple trained the algorithm on data from more than 100,000 participants and clinically validated it with over 2,000 more, per MobiHealthNews’ reporting. If the pattern looks concerning, the watch tells the wearer to confirm with a traditional cuff and see a doctor — it explicitly does not detect every case of hypertension. Apple has said it expects the feature to notify more than a million people of a possible undiagnosed condition within its first year.
Samsung’s Galaxy Watch also has a blood pressure feature that’s now available to US users as of early 2026, but it runs under a completely different regulatory path. According to SamMobile, Samsung has confirmed the tool is not FDA-cleared or approved; it’s offered under the FDA’s general wellness policy for consumer devices, and Samsung itself says it isn’t a substitute for a medical-grade monitor. Fitbit and Google’s Pixel Watch line don’t have a shipping blood pressure feature in the US as of this writing, though Android Central has reported that Google appears to be testing a similar hypertension-screening capability. Garmin has not brought a blood pressure feature to its mainstream watches.
What’s the Difference Between a “Trend” Feature and a Real Reading?
A “trend” or “screening” feature analyzes a pattern over time and tells you whether something looks off; a “reading” gives you an actual systolic/diastolic number at that moment, the way a cuff does. This distinction is the single most important thing to understand before buying any blood pressure wearable, because marketing language often blurs it.
Apple’s hypertension notification is a trend feature: it never states a number, just an alert. Samsung’s Galaxy Watch feature and most Hilo/Aktiia-technology bands sold direct to consumers produce a daily estimated number, which feels like a reading, but under current US regulation that estimate is usually offered as wellness information rather than a cleared diagnostic measurement — meaning the company itself says not to use it to adjust medication or diagnose a condition. Only a true oscillometric reading (an inflating cuff, wrist or arm) or an FDA-cleared cuffless medical system counts as a reading in the clinical sense.
When Wearable Blood Pressure Monitoring Started Making Sense
The category didn’t move in a straight line from “marketing hype” to “cleared medical device.” It moved in fits: years of wellness-only optical sensors that couldn’t back up their claims, then Omron’s HeartGuide in 2018 proving a real cuff could fit on a wrist (at the cost of bulk and a $500 price tag), then a long gap where nothing else cleared until Aktiia’s G0 system in July 2025 became the first FDA-cleared cuffless monitor. Apple’s hypertension notification followed two months later, in September 2025, as the first passive screening feature from a mainstream smartwatch maker. Samsung’s wellness-path blood pressure tool reached US users in early 2026, still uncleared but no longer geofenced out of the market.
The through-line is this: real regulatory clearance took years longer than the marketing did. Wearable makers were talking about blood pressure monitoring as early as 2016, but the FDA didn’t clear a cuffless system until 2025, and even that cleared system isn’t the version most consumers can buy off the shelf today. The gap between “this device mentions blood pressure” and “this device is cleared to measure it” is still the category’s defining feature in 2026.
Which Cuffless Blood Pressure Wearables Are FDA-Cleared, and Which Are Just “Wellness”?
This is where the category gets genuinely confusing, even for people who follow it closely, because one company has both a cleared system and a wellness product on the market under related branding. The Swiss company Aktiia developed a cuffless pulse-wave-analysis system, marketed under the Hilo name, that estimates blood pressure continuously from an optical wrist sensor.
In July 2025, Aktiia’s underlying system — referred to as the G0 Blood Pressure Monitoring System — received FDA 510(k) clearance as an over-the-counter cuffless blood pressure monitor, which PR Newswire and MobiHealthNews both reported as a first for the category. Aktiia co-founder Dr. Josep Solà called clearing the OTC bar “a rare and demanding bar to meet,” and the technology had already carried a CE mark as a Class IIa medical device in Europe. That’s a genuinely significant regulatory milestone.
But the product Hilo launched to US consumers in July 2026, called Hilo Core, is a different animal. According to Forbes contributor David Phelan’s hands-on coverage, Hilo Core costs $89.99 for the wristband plus a calibration cuff, and $149.99 a year for the subscription. Reporting from MobiHealthNews on the launch clarifies that Hilo Core is explicitly not the FDA-cleared G0 system — it’s positioned as “a general wellness product for awareness and lifestyle insights,” and the company has said it doesn’t currently plan to expand it into a regulated medical platform. Hilo’s own product page states plainly that Hilo Core “is designed for wellness and awareness, not medical use” and “does not provide diagnosis, treatment, or clinical monitoring,” even though the included calibration cuff is itself FDA-cleared. In practice: the science behind Hilo Core has real regulatory credibility, but the retail band you can buy today isn’t the cleared medical device — it’s a wellness product built on that technology.
Is There a Wearable With an Actual Blood Pressure Cuff?
Yes — Omron’s HeartGuide, which has carried FDA 510(k) clearance since November 2018 and remains, as far as we could verify, the only mainstream wrist-worn device that measures blood pressure the same way a doctor’s office does. Instead of estimating pressure optically, the HeartGuide’s watchband contains a genuine inflatable cuff that performs an oscillometric measurement on demand, the identical method used in clinical-grade upper-arm monitors.
That real cuff is also the tradeoff: the band has to inflate around your wrist to take a reading, which is slower and less discreet than glancing at a screen, and the watch currently retails around $499, according to a device breakdown from Healthcare Discovery. Wrist position relative to heart level also matters more than it does with an upper-arm cuff; getting the arm angle wrong can introduce meaningful error. It’s a legitimate medical-grade device, not a fitness-tracker feature bolted onto blood pressure, and that’s reflected in both its price and its clearance.
How Do the Different Technology Types Compare?
To cut through the marketing language, here’s how the major categories stack up side by side — grouped by the underlying technology and its true regulatory status, not by brand name.
| Technology type | Regulatory status | What it tells you | Approx. cost (2026) |
|---|---|---|---|
| Cuffless optical “trend/screening” (e.g. Apple Watch hypertension notifications) | FDA-cleared as a notification algorithm | Whether your 30-day vascular pattern looks consistent with possible hypertension — never a number | Included with a watch you may already own (~$400–$800) |
| Cuffless optical “wellness estimate” (e.g. Samsung Galaxy Watch BP, Hilo Core) | Unregulated wellness feature or wellness product under FDA’s general wellness policy | A daily estimated systolic/diastolic number for personal awareness, not diagnosis | Free with watch, or ~$90 band + ~$150/yr subscription (Hilo Core) |
| Cuffless optical, FDA-cleared medical system (Aktiia/Hilo “G0” system) | FDA 510(k)-cleared, over-the-counter | An cleared blood pressure estimate, though still calibrated periodically against a cuff | Not yet broadly retail-priced as the cleared version in the US as of publication |
| Cuff-integrated oscillometric wearable (Omron HeartGuide) | FDA 510(k)-cleared blood pressure monitor | A true on-demand oscillometric reading, same method as a clinical cuff | ~$499 |
| Standard home upper-arm cuff monitor | FDA-cleared / clinically validated (check validatebp.org) | The most accurate reading available outside a clinic — the reference standard | ~$30–$80 |
How Accurate Is Cuffless Optical Blood Pressure Sensing, Really?
Independent cardiology researchers say the category is promising but not yet ready to replace a cuff for clinical decisions. The American Heart Association published a scientific statement on cuffless blood pressure devices, and its writing group chair, Dr. Jordana Cohen of the University of Pennsylvania’s Perelman School of Medicine, put it directly in coverage summarized by the American Heart Association’s own newsroom: “The speed of commercialization has outpaced the science.”
The AHA statement notes that formal accuracy validation lags well behind the number of devices being sold, and that performance can shift with arm or wrist position, skin tone, how recently the device was calibrated against a cuff, and activity like exercise or sleep. Its bottom line for consumers and clinicians is not to use unvalidated cuffless readings to make treatment decisions on their own, and to tell your doctor if you’re tracking blood pressure with any wearable so the numbers can be put in context. Dr. Cohen also struck an optimistic note, saying the devices “have the potential to transform hypertension care when their accuracy and reliability improve” — this is a young, fast-moving category, not a dead end.
Which Wearable Should You Buy for Which Health Goal?
Blood pressure is just one of several things wearables attempt to track, and it’s usually not the category’s strongest suit yet. If your goal isn’t blood pressure specifically, a different feature set is probably a better reason to buy.
- Heart rate and HRV: the most mature wearable metric across the board — optical heart rate sensors are well-validated for continuous tracking, and most mainstream watches, including the one covered in our Samsung Galaxy Watch FE review, handle this reliably.
- Sleep tracking: useful for spotting patterns (consistency, disruptions, rough sleep stages), though stage-by-stage accuracy still varies by brand and algorithm — treat it as directional, not clinical.
- Recovery and readiness scores: genuinely useful for endurance athletes and anyone trying to avoid overtraining; Garmin and similar training-focused devices, like the one we reviewed in our Garmin Forerunner 165 review, tend to lead here.
- Everyday activity tracking: steps, active minutes, and workout logging are reliable and require no medical-grade sensor — a budget band from our best fitness trackers under $100 roundup covers this just fine.
- Fall detection: a genuinely valuable safety feature for older adults or anyone living alone, available on several mainstream smartwatches, and worth prioritizing over blood pressure claims if that’s your household’s real concern.
For a broader look at how these categories fit together across current devices, our phones and wearables coverage rounds up more specific picks.
So Should You Buy a Blood Pressure Wearable in 2026?
Buy one if you understand exactly what it’s cleared to do, and buy the right category for your goal. If you want an early nudge that something might be off, Apple’s hypertension notification is a reasonable, genuinely FDA-cleared bonus feature on a watch you’d likely buy anyway. If you specifically want on-wrist numbers you can somewhat trust, the Omron HeartGuide’s real cuff is the more honest technology, at a real cost and inconvenience premium. If you manage hypertension with a doctor, a validated upper-arm home cuff — checked against validatebp.org — is still the most accurate and least expensive option, wearable or not.
What we’d steer you away from is treating any cuffless wellness estimate, including Samsung’s or Hilo Core’s, as a diagnostic tool, or delaying a real medical evaluation because a wearable’s trend looked fine. The technology is moving fast and the AHA statement itself frames this as improving rather than static, but 2026 is still a “verify with a cuff, and see a doctor” moment for this whole category — not a “trust the wrist” moment yet.
Blood Pressure Wearable Questions
Is any smartwatch FDA-approved to measure blood pressure?
No smartwatch is “FDA-approved” for blood pressure — that’s the wrong term for this category. Apple Watch’s hypertension feature is FDA-cleared, but only as a 30-day trend notification, not a direct blood pressure reading. Omron’s HeartGuide is FDA-cleared with an inflatable cuff that produces a real reading. “Cleared” and “approved” are different regulatory terms, and neither applies to most smartwatch blood pressure features, which run as unregulated wellness tools instead.
Can the Apple Watch tell me my blood pressure number?
No. Apple Watch’s hypertension notification feature analyzes 30 days of optical sensor data and alerts you if the pattern looks consistent with hypertension — it never displays a systolic or diastolic number, and Apple has said it won’t catch every case.
Is the Hilo Band the same as the FDA-cleared Aktiia device?
Not exactly. Aktiia’s underlying G0 system received FDA 510(k) clearance in July 2025, but the consumer product Hilo launched in the US in 2026, called Hilo Core, is sold as a separate wellness product that is explicitly not positioned as that cleared medical system, according to the company’s own product page and launch coverage.
What is the most accurate wearable blood pressure device available?
Among wearables, Omron’s HeartGuide is the closest to clinical accuracy because it uses a real inflatable cuff and oscillometric measurement rather than optical estimation. But independent researchers, including the American Heart Association, still consider a validated standard upper-arm home cuff the most accurate at-home option overall.
Should I trust a cuffless blood pressure wearable to manage my hypertension?
Not on its own. The American Heart Association’s scientific statement on cuffless devices cautions that accuracy validation hasn’t kept pace with how many devices are on the market, and recommends against using unvalidated cuffless readings to make treatment decisions without a healthcare professional’s involvement.
This guide is based on publicly reported regulatory filings, manufacturer product pages, and independent journalism and clinical commentary — not hands-on lab testing of blood pressure accuracy, which requires clinical equipment we don’t have. We cross-referenced FDA clearance claims against outlet reporting (MobiHealthNews, Cardiovascular Business, Forbes, SamMobile, and others cited in-line above), reviewed the American Heart Association’s scientific statement on cuffless devices for expert consensus, and read manufacturer disclaimers directly from product pages rather than relying on marketing summaries. Where owner and reviewer feedback is referenced, it reflects long-term patterns reported by outside sources, not our own testing. For our full approach, see our editorial standards. Prices are approximate, current as of publication, and change frequently — confirm the latest price with the retailer before buying.
Published August 7, 2026. Last updated August 28, 2026.
